Cargando…
Plasma lipoprotein(a) levels in patients with slow coronary flow
INTRODUCTION: Slow coronary flow (SCF) is a microvascular disorder characterized by delayed opacification of coronary vessels with normal coronary angiogram. It may be due to endothelial dysfunction and diffuse atherosclerosis. Lipoprotein(a) [Lp(a)] is related to cardiovascular events. Plasma Lp(a)...
Autores principales: | Yucel, Habil, Dogan, Abdullah, Altinbas, Ahmet, Akcay, Salaheddin, Icli, Atilla, Ceyhan, Betul Mermi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927102/ https://www.ncbi.nlm.nih.gov/pubmed/24570746 http://dx.doi.org/10.5114/pwki.2013.38404 |
Ejemplares similares
-
Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow
por: Ding, Yao-dong, et al.
Publicado: (2020) -
The Effect of Slow Coronary Flow on Right and Left Ventricular Performance
por: Altunkas, Fatih, et al.
Publicado: (2013) -
Endothelial function and germ-line ACE I/D, eNOS and PAI-1 gene profiles in patients with coronary slow flow in the Canakkale population: multiple thrombophilic gene profiles in coronary slow flow
por: Gazi, Emine, et al.
Publicado: (2014) -
The effect of blood cell count on coronary flow in patients with coronary slow flow phenomenon
por: Soylu, Korhan, et al.
Publicado: (2014) -
Evaluation of homocystein and asymmetric dimethyl arginine levels in patients with coronary slow flow phenomenon
por: Demirci, Erkan, et al.
Publicado: (2019)